All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your Lymphoma Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
Visit:
ALL Hub

ALL Hub

AML Hub

AML Hub

GvHD Hub

GvHD Hub

Lupus Hub

Lupus Hub

MPN Hub

MPN Hub

Multiple Myeloma

Multiple Myeloma Hub

PsOPsA Hub

PsOPsA Hub

LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
Steering CommitteeAbout UsNewsletterContact
SubtypesTherapeuticsCongressesTrialsExpert OpinionsDRUG UPDATES
2020-11-23T16:31:53.000Z

ASH 2019 | Practice-changing abstracts in lymphoma and CLL

By Ulrich Jäger, Susan O'Brien, Martin Dreyling, Constantine Tam, Gilles Salles, Francesc Bosch, Anton Hagenbeek, Astrid Pavlovsky, Judith Trotman, Irene Biasoli
Nov 23, 2020
Share:

Bookmark this article

Did you miss ASH 2019? The Lymphoma Hub attended the 61st ASH Annual Meeting & Exposition, December 7-10 2019, Orlando, US, and has developed a downloadable resource on the practice-changing abstracts in lymphoma and CLL.

In this resource, you will find comments from the Lymphoma Hub Steering Committee members on DLBCL prognostic factors, MCL novel treatment options, FL chemo-free treatment options, treating patients with newly diagnosed CLL, R/R CLL, and poor-prognosis NHL, and the role of maintenance therapy in Waldenstrӧm’s macroglobulinemia.

Updated November 24, 2020. 

ASH 2019 | Practice-changing abstracts in lymphoma and CLL

If you would like to view the practice-changing abstracts from ASH 2019 and the expert opinions from our Steering Committee, please download the resource below.

Download Here

More about...
Aggressive B-cell lymphomasAIMAnaplastic large cell lymphomaAntibody therapyASH 2019AUGMENTCAPTIVATECAR therapyChronic lymphocytic leukemiaChronic lymphocytic leukemiasDiffuse large B-cell lymphomaE1912ELEVATE-TNFollicular lymphomaIndolent B-cell lymphomasKinase inhibitorsMAINTAINMantle cell lymphomaMantle cell lymphomasMature T and NK cell neoplasmsWaldenström’s macroglobulinemia

Understanding your specialty helps us to deliver the most relevant and engaging content.

Please spare a moment to share yours.

Please select or type your specialty

  Thank you

Related articles

Add bookmark

What is the familial risk of developing a hematological malignancy? 

This article provides a summary of a study by Amit Sud and colleagues, which aimed to investigate the familial risks in hematological malignancies using a large database registry in...

Sep 9, 2019
Add bookmark

What is the familial risk of developing a hematological malignancy? 

This article provides a summary of a study by Amit Sud and colleagues, which aimed to investigate the familial risks in...

Sep 9, 2019
Add bookmark

New chemotherapy-free approaches for the treatment of lymphoid malignancies

At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances in chemotherapy-free options in the field of...

Jul 30, 2019
Add bookmark

New chemotherapy-free approaches for the treatment of lymphoid malignancies

At the 15th International Conference on Malignant Lymphoma, the Lymphoma Hub Satellite Symposium highlighted recent advances...

Jul 30, 2019

Newsletter

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox